Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × famitinib × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 2 Cervical Cancer Metastatic 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Non-squamous Non-small-cell Lung Cancer 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

lutetium Lu 177 dotatate 5 pasireotide 2 amino-acid, glucose, and electrolyte solution 2 Octreotide 2 Everolimus 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 zimberelimab 1 lanreotide 1 irinotecan sucrosofate 1 gallium Ga 68 dotatate 1 copper dotatate CU-64 1 abemaciclib 1 Temozolomide 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 PM 01183 1 Oxaliplatin 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Ga(III)-DOTATOC 1 Folfox protocol 1 Fluorouracil 1 E-7386 1 Disulfides 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡